# Eledon Pharmaceuticals, Inc. (ELDN): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/eldn for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating innovative treatments for individuals battling autoimmune disorders, amyotrophic lateral sclerosis (ALS), and those undergoing organ or cell transplantation. Their flagship therapeutic candidate, AT-1501, is a humanized monoclonal antibody engineered to specifically target CD40 Ligand, a crucial protein found on the surface of immune system T cells. This compound is currently undergoing Phase 2a clinical studies for ALS treatment and Phase 2 trials for islet cell transplantation, aiming to address...

## Quote & Key Metrics

As of 2026-10-26:

| Metric | Value |
|---|---|
| Price | $2.25 USD |
| Market Cap | $182.8M |
| P/E (TTM) | — |
| EPS (TTM) | −$0.91 |
| 52-Week Range | $1.35 – $4.60 |
| Dividend Yield (TTM) | — |

## Dividend

ELDN has no dividend payment history in our records.

## Frequently Asked Questions

### What does Eledon Pharmaceuticals, Inc. do?

Eledon Pharmaceuticals, Inc. (ELDN) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ELDN's market cap?

Eledon Pharmaceuticals, Inc. (ELDN) has a market capitalization of approximately $182.8 million, as of October 26, 2026, based on the most recent share price and shares outstanding.

### Does ELDN pay a dividend?

No, Eledon Pharmaceuticals, Inc. (ELDN) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ELDN profitable?

Eledon Pharmaceuticals, Inc. (ELDN) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ELDN ever paid a dividend?

No. Dividend Data's records show no dividend payments from Eledon Pharmaceuticals, Inc. (ELDN). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/eldn
- Dividend history & safety: https://www.dividenddata.com/stocks/eldn/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/eldn/earnings
- Financial statements: https://www.dividenddata.com/stocks/eldn/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/eldn/valuation
- Peer comparison: https://www.dividenddata.com/stocks/eldn/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.